Does Tennessee's Prohibition on Medical Procedures Performed on Minors Related to Sexual Identity (SB1) violate the Equal Protection Clause of the Fourteenth Amendment? The Court must determine if the law's restrictions on puberty blockers and hormones for transgender minors trigger heightened scrutiny or are subject only to rational basis review. Specifically, the case asks whether SB1 classifies based on sex or transgender status.

• SB1 relies on sex-based classifications because it prohibits medical care that enables a minor to live as an identity "inconsistent with the minor's sex," thereby forcing conformity to sex stereotypes.
• Transgender individuals constitute a quasi-suspect class, which should trigger intermediate scrutiny under the Equal Protection Clause.
• Under the reasoning of *Bostock v. Clayton County*, discriminating against transgender status is inherently discrimination based on sex because it penalizes one sex for traits tolerated in the other.
• The law's categorical ban fails to account for medical necessity and ignores a broad consensus among major medical associations that such care is appropriate when clinically indicated.

• SB1 does not classify by sex but rather by age (minors vs. adults) and medical use (treating gender dysphoria vs. treating congenital defects or disease).
• The law treats all minors the same regardless of biological sex; it simply removes specific diagnoses—gender dysphoria, gender identity disorder, and gender incongruence—from the range of treatable conditions.
• Tennessee has a legitimate state interest in protecting minors from irreversible risks, including sterility and adverse psychological consequences, especially given that minors lack the maturity to appreciate such harms.
• The State is entitled to legislative flexibility because there is significant medical and scientific uncertainty regarding the long-term safety and efficacy of these treatments.

• SB1 does not violate the Equal Protection Clause because it is not subject to heightened scrutiny and satisfies rational basis review.
• The Court held that SB1 incorporates only two classifications—age and medical use—neither of which warrants heightened review under *Massachusetts Bd. of Retirement v. Murgia* and *Vacco v. Quill*.
• Mere reference to sex in a statute is insufficient to trigger heightened scrutiny, particularly in a medical context where treatments are often uniquely bound up in biological sex (*Tuan Anh Nguyen v. INS*).
• The Court defined "medical treatment" as encompassing both the drug administered and the specific indication for which it is used; thus, treating gender incongruence is a different treatment than treating precocious puberty, regardless of the patient's sex.
• SB1 does not classify based on transgender status because it removes a set of diagnoses from treatable conditions rather than excluding a class of people, creating a "lack of identity" between the status and the diagnosis similar to the reasoning in *Geduldig v. Aiello*.
• The Court declined to extend the but-for causation test from *Bostock v. Clayton County* to the Equal Protection Clause here, noting that changing a minor's sex would not alter the application of SB1 because the patient would still lack a qualifying diagnosis.
• Under the rational basis test from *FCC v. Beach Communications, Inc.*, the law is upheld if there is "any reasonably conceivable state of facts" providing a rational basis for the classification.
• The Court found that Tennessee's findings regarding irreversible sterility, psychological risks, and minor immaturity are rationally related to the objective of protecting minors' health and welfare.
• States possess "wide discretion to pass legislation in areas where there is medical and scientific uncertainty," as seen in *Gonzales v. Carhart*.